Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-01-02 @ 10:27 PM
Study NCT ID:
NCT03259867
Status:
RECRUITING
Last Update Posted:
2024-11-22
First Post:
2017-08-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of TATE and PD-1 Inhibitor in Liver Cancer
Sponsor:
Teclison Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2017-08-16
First Submit QC Date:
None
Study First Post Date:
2017-08-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-19
Last Update Post Date:
2024-11-22
Last Update Post Date Type:
ACTUAL